Akebia Therapeutics's market cap is currently $440.51M. The company's EPS TTM is $0; its P/E ratio is -21.81; Akebia Therapeutics is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is lt;0.01. See an overview of income statement, balance sheet, and cash flow financials.
